The efficacy of combination of risperidone and fluoxetine in obsessive compulsive patients
Phase 2
- Conditions
- Obsessive-compulsive disorder.Anxiety disorder
- Registration Number
- IRCT201103083010N2
- Lead Sponsor
- Vice-chancellor for research, Kermanshah University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
obsessive compulsive disorder, New case , age>18, age<65, Yale Brown rating scale >16. Exclusion criteria: substance abuse, comorbid of psychotic disorder, suicidal ideation, Yale Brown rating.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response to treatment. Timepoint: Before treatment, 6weeks after treatment , 12weeks after treatment. Method of measurement: Obsessive compulsive qustioner (Y-Bocs).
- Secondary Outcome Measures
Name Time Method Clinical side effects. Timepoint: 6 and 12 weeks after treatment. Method of measurement: According to patients report.